News: Molecular Biosciences
Read the latest news from the College of Natural Sciences at The University of Texas at Austin
UT News
Campus Event to Celebrate Health and Science Heroes Linked to COVID-19 Vaccines
UT Austin scientists have been at the forefront of the race for coronavirus vaccines and the efforts to track and prevent its spread.
Molecular Biosciences Professor Honored for Outstanding Teaching
Janice Fischer is honored for her outstanding teaching as a professor of molecular biosciences and director of the Biology Instructional Office at UT Austin.
McLellan Honored for Contributions to COVID-19 Vaccines
Jason McLellan, UT Austin molecular biosciences professor, has received the 2021 Shirley Bird Perry Longhorn Citizenship Award
Department of Molecular Biosciences
As Cryo-EM Capabilities Expand, Cool Science at UT Gets a Boost
Support from Tito's Handmade Vodka, the U.S. Army and Judy and Henry Sauer will expand the capabilities of the campus cryo-electron microscopy facility
Department of Molecular BIosciences
Jason McLellan Named Texas Inventor of the Year
For his role in biomedical research linked to the development of vaccines and treatments for COVID-19, the professor of molecular biosciences won the award given...
Department of Molecular Biosciences
New Insights Could Lead to Crops Adapted to a Warming World
A new study offers hope that breeders will be able to develop crops that can tolerate higher temperatures while also maintaining high yield
Department of Molecular Biosciences
'Last Resort' Antibiotic Pops Bacteria Like Balloons
A new study reveals that colistin, a last resort antibiotic “punches holes in bacteria, causing them to pop like balloons.”
Department of Molecular Biosciences
Our Immune Systems Blanket the SARS-CoV-2 Spike Protein with Antibodies
Most antibodies against SARS-CoV-2 circulating in the blood target areas of the viral spike protein outside the receptor binding domain, or RBD
Department of Molecular Biosciences
Hepatitis C Drugs Boost Remdesivir’s Antiviral Activity Against COVID-19
Four drugs used to treat hepatitis C render remdesivir 10 times better at inhibiting the coronavirus in cell cultures.
Department of Molecular Biosciences
Human Trials Begin for a Low-Cost COVID-19 Vaccine to Extend Global Access
A COVID-19 vaccine in human trials in Vietnam, Thailand and Brazil, holds promise for affordable vaccine manufacturing in countries currently dependent on imported vaccines.